NeupogenTM
Showing 1 - 8 of 8
Angiosarcoma Trial in Houston (Paclitaxel, mRNA plus Lysate-loaded Dendritic Cell Vaccine, PEGYLATED-INTERFERON ALPHA-2A)
Not yet recruiting
- Angiosarcoma
- Paclitaxel
- +3 more
-
Houston, TexasM D Anderson Cancer Center
Mar 23, 2023
Myeloma Trial in Houston (drug, other, procedure)
Completed
- Myeloma
- Busulfan
- +5 more
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Apr 7, 2020
Recurrent Implantation Failure, Endometriosis Trial (Granulocyte Colony-Stimulating Factor, Intrauterine infusion of normal
Unknown status
- Recurrent Implantation Failure
- Endometriosis
- Granulocyte Colony-Stimulating Factor
- Intrauterine infusion of normal saline
- (no location specified)
May 26, 2018
Leukemia, Lymphoma, Myeloma Trial in Houston (Fludarabine, Melphalan, Alemtuzumab)
Terminated
- Leukemia
- +3 more
- Fludarabine
- +8 more
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Feb 18, 2016
Lymphoma Trial in Houston (Vorinostat, Gemcitabine, Busulfan)
Completed
- Lymphoma
- Vorinostat
- +8 more
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Nov 17, 2015
Myelodysplastic Syndrome, Aplastic Anemia Trial in Houston (Thymoglobulin, Cyclosporine, Methylprednisolone)
Completed
- Myelodysplastic Syndrome
- Aplastic Anemia
- Thymoglobulin
- +3 more
-
Houston, TexasUT MD Anderson Cancer Center
Mar 8, 2013
Multiple Myeloma Trial in Houston (Pegfilgrastim (Neulasta), Apheresis)
Completed
- Multiple Myeloma
- Pegfilgrastim (Neulasta)
- Apheresis
-
Houston, TexasMD Anderson Cancer Center
Jul 31, 2012
Non-Hodgkin's Lymphoma Trial in Houston (Rituximab)
Terminated
- Non-Hodgkin's Lymphoma
-
Houston, TexasUT MD Anderson Cancer Center
Jul 27, 2012